1. A8.24 PPARβ/δ expression orchestrates the immunosuppressive effect of mesenchymal stem cells via NF-κB signalling. (13th February 2015) Authors: Luz-Crawford, P; Ipseiz, N; Caicedo, A; Scholtysek, C; Stoll, C; Loriau, J; Tejedor, G; Jorgensen, C; Kronke, G; Djouad, F Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NR4A1 modulates the inflammatory response during murine experimental arthritis. (4th April 2011) Authors: Scholtysek, C; Uderhardt, S; Schett, G; Krönke, G Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P148 JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss. (March 2019) Authors: Adam, S; Simon, N; Steffen, U; Andes, F; Müller, D; Culemann, S; Andreev, D; Hahn, M; Scholtysek, C; Schett, G; Krönke, G; Frey, S; Hueber, A Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis. Issue 12 (8th March 2016) Authors: Luz-Crawford, P; Ipseiz, N; Espinosa-Carrasco, G; Caicedo, A; Tejedor, G; Toupet, K; Loriau, J; Scholtysek, C; Stoll, C; Khoury, M; Noël, D; Jorgensen, C; Krönke, G; Djouad, F Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 12(2016) Page Start: 2166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗